News roundup Friday, April 26

The latest from BioStock

» Prolight Diagnostics completes test card design
» Oncoinvent strengthens the board and treasury
» VibroSense Dynamics takes on new markets
» Xintela's CEO: “We are advancing business development”
» Strong investment and product development in Toleranzia's focus area myasthenia gravis

Read BioStock's weekly newsletter for v.16 here.

News from the last 24 hours

Last patient treated in phase II study confirms promising efficacy signals and no safety concerns. Read more.

The board of directors Alzinova decides on a rights issue of shares of approximately SEK 34,4 million. Read more.

Lytix Biopharma announces approval of Phase II study in early-stage skin cancer. Read more.

Alligator Bioscience and Orion Corporation announces that development opportunities have been utilized within the companies' immuno-oncology research collaboration and licensing agreement from 2021. Read more.

Mentice intends to present the Q1 report via webcast on May 3. Read more.

OncoZenge publishes report on BupiZenge and unmet medical needs. Read more.

Brain+ announces that a successful CST course for dementia has been held for Malteser Germany. Read more.

BlackRock flags up in Orion Corporation. Read more.

Attana is entering the third year of a five-year service and support contract from a leading health institute in the United States. Read more.

Abliva decides on a directed issue of shares to guarantors in connection with the completed rights issue. Read more.

Annastiina Kauppinen appointed as Chief Financial Officer for BBS-Bioactive Bone Substitutes. Read more.

Integral comments on the closure of the Center for Bionics and Pain Research. Read more.

Last day for trading in the warrants of series TO4 in Peptonic Medical Today is April 26th. Read more.

The board of directors Lifecare proposes a partially guaranteed rights issue. Read more.

ADDvise publishes a bond prospectus and applies for admission to trading of bonds on Nasdaq Stockholm. Read more.

Contigo Care announces the outcome of the directed new share issue. Read more.

Mats Gustafsson appointed CFO in NeoDynamics. Read more.

Toleranzia receives a loan commitment of SEK 20 million. Read more.

Change in the nomination committee's proposal for election of the board of directors in Bio-Works. Read more.